Who are Polydeoxyribonucleotide Injection's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/polydeoxyribonucleotide-injection.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Polydeoxyribonucleotide Injection — Competitive Intelligence Brief

Polydeoxyribonucleotide Injection (Polydeoxyribonucleotide Injection) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Biogenic nucleotide/tissue repair agent. Area: Dermatology, Wound Healing, Regenerative Medicine.

marketed Biogenic nucleotide/tissue repair agent Adenosine receptors (A2A) Dermatology, Wound Healing, Regenerative Medicine Small molecule Live · refreshed every 30 min

Target snapshot

Polydeoxyribonucleotide Injection (Polydeoxyribonucleotide Injection) — Chuncheon Sacred Heart Hospital. Polydeoxyribonucleotide (PDRN) is a naturally occurring polynucleotide that promotes tissue repair and regeneration by stimulating cellular metabolism and growth factor production.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Polydeoxyribonucleotide Injection TARGET	Polydeoxyribonucleotide Injection	Chuncheon Sacred Heart Hospital	marketed	Biogenic nucleotide/tissue repair agent	Adenosine receptors (A2A)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Biogenic nucleotide/tissue repair agent class)

Chuncheon Sacred Heart Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Polydeoxyribonucleotide Injection — Competitive Intelligence Brief. https://druglandscape.com/ci/polydeoxyribonucleotide-injection. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab